Results 101 to 110 of about 26,238 (200)

Production of Medical Radionuclides in the Center for Radiopharmaceutical Tumor Research—A Status Report

A new Center for Radiopharmaceutical Cancer Research was established at the Helmholtz-Zentrum Dresden-Rossendorf in 2017 to centralize radionuclide and radiopharmaceutical production, as well as enable chemical and biochemical research.
Klaus Kopka, Torsten Knieß, Martin Kreller, Santiago Andrés Brühlmann, Martin Walther   +4 more
core   +1 more source

Assessing Value for Money in Theranostic Nuclear Medicine: A Systematic Review. [PDF]

J Nucl Med
Wang Y, Wood JL, Thurecht KJ, Yeoh SY, Tuffaha H.   +4 more
europepmc   +1 more source

Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?

Background: Radiopharmaceuticals have been considered a special group of medicines in Europe since 1989. The use of radiopharmaceuticals that have marketing authorization should always be the first option in clinical use, however due to their special ...
Moya, Estrella, Cerrato, Celia, Guerra Guirao, José Antonio, Bedoya, Luis M, Bedoya Del Olmo, Luis Miguel, Guerra, José Antonio   +5 more
core   +1 more source

AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. [PDF]

J Med Internet Res
Cuffari B.
europepmc   +1 more source

Quantitative Bone Scintigraphic Follow-Up After a 2-Month Cross-Training Program Including Swimming in Showjumping Horses with Back and Neck Pain. [PDF]

Animals (Basel)
Prémont A, Moiroud C, Jacquet S, Beaumont A, Bertoni L, Chateau H, Audigié F.   +6 more
europepmc   +1 more source

Artificial Intelligence for Simplified Patient-centered Dosimetry in Radiopharmaceutical Therapies.

Patient-specific dosimetry is currently a clinical need to evaluate lesion and organs at risk evolution in radiopharmaceutical therapy (RPT).
Rahmim, Arman, Seifert, Robert, Zaidi, Habib, Chen, Yizhou, Rominger, Axel, Salimi, Yazdan, Shi, Kuangyu, Uribe, Carlos, Afshar-Oromieh, Ali, Yousefirizi, Fereshteh, Lopez Montes, Alejandro   +10 more
core   +1 more source

Optimization of Gravity Infusion Protocols for ¹⁷⁷Lu-DOTATATE Administration in Peptide Receptor Radionuclide Therapy. [PDF]

Pharmaceutics
Grasso S, Varallo A, Gaudieri V, Klain M, Pastore R, Arena S, Oliviero C, Buono M, Manzi D, Schiano R, Nappi C, Totaro P, Bonifacio RR, Cuocolo A, Clemente S.   +14 more
europepmc   +1 more source

The next evolution of theranostics: from target discovery to integrated precision medicine. [PDF]

Front Med (Lausanne)
Montemagno C, Serrano B, Paulmier B.
europepmc   +1 more source

Artificial Intelligence in Nuclear Medicine (2015-2025): Clinical Applications, Regulatory Governance, and Pharmacotherapeutic Implications. [PDF]

Cureus
Alpizar-Rojas M, Jaromirski-Segura H, Herrera-Jiménez LG, Castro-Gamboa JA, Mora-Jiménez J, Arguedas-Chacón S, Zavaleta-Monestel E.   +6 more
europepmc   +1 more source

Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [¹¹C]AZ14193391. [PDF]

EJNMMI Res
Törnblom A, He C, Bolin M, Tzortzakakis A, Fernebro J, Li C, Fridsten S, Altena R, Axelsson R, Siikanen J, Hindorf C.   +10 more
europepmc   +1 more source